Metabolic dysfunction-associated fatty liver disease (commonly known as MAFLD) impacts
global health in epidemic proportions, and the resulting morbidity, mortality and economic …

Obtaining an imaging diagnosis of various hepatobiliary and pancreatic disorders caused by
certain drugs can often be challenging. Familiarity with these conditions may improve …

Amiodarone (AMD) is a widely used antiarrhythmic drug prescribed to treat cardiac
tachyarrhythmias; however, AMD has been reported to provoke pulmonary fibrosis (PF) and …

Лекарственно-ассоциированная жировая болезнь печени (ЛЖБП) это группа
осложнений фармакотерапии, распространенность которых составляет около 10% от …

New phenylethylamine derivatives are among the most commonly abused new
psychoactive substances. They are synthesized and marketed in lieu of classical …

Amiodarone is a class III antiarrhythmic agent that inhibits adrenergic stimulation by blocking
alpha and beta receptors. It prolongs action potential and refractory period in myocardial …

Objetivo: Verificar as possíveis causas de tireoidopatia associada à amiodarona. Revisão
bibliográfica: A grande quantidade de iodo na sua composição, inibição das deiodinases …

The liver is the largest solid organ, the largest gland, and one of the most vital organs that
functions as a center for the metabolism of nutrients and excretion of waste metabolites …

Drug-induced liver injury (DILI) is one of the leading causes of liver failure and withdrawal of
drugs from the market. A poor understanding of the precipitating event aetiology and …

Drug-induced fatty liver disease (DIFLD) covers a group of adverse drug reactions whose
prevalence accounts for about 10% of all adverse reactions. The aim of this review was to …